Equity incl. NCI
Balance – as of period end · $M
FY2018
−27$M
All values (10)
| Period | Value ($M) | Status |
|---|---|---|
| FY2026 | 9,808 | reported |
| FY2025 | 8,935 | reported |
| FY2024 | 8,019 | reported |
| FY2023 | 6,207 | reported |
| FY2022 | 5,780 | reported |
| FY2021 | 3,861 | reported |
| FY2020 | 834 | reported |
| FY2019 | −7 | reported |
| FY2018 | −27 | reported |
| FY2017 | −29 | reported |
| FY2016 | – | missing: No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: equity_total
More metrics for Zoom
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Sources & calculation
- Value
- −$27.0M
- Period
- FY2018, ended Jan 31, 2018 · as of Jan 31, 2018 (balance as of date, not a sum)
- Source
- 10-K, filed Mar 20, 2020 · 0001585521-20-000095
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | −$27.0M | Mar 20, 2020 | 10-K 0001585521-20-000095 | reported · confidence 1. · current |